Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | SRC | P12931 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | PGD | P52209 | 1/20 | 0.30 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.30 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.30 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2200092 | 1.00 | TSHR (0.50) | TSHRSRCTP53PGDMMP1 | |
| SCHEMBL8145944 | 1.00 | TSHR (0.50) | TSHRSRCTP53PGDMMP1 | |
| SCHEMBL5691242 | 1.00 | TSHR (0.50) | TSHRSRCTP53PGDMMP1 | |
| SCHEMBL5691239 | 1.00 | TSHR (0.50) | TSHRSRCTP53PGDMMP1 | |
| SCHEMBL29292859 | 0.98 | TSHR (0.48) | TSHRSRCTP53 | |
| SCHEMBL20565536 | 0.98 | TSHR (0.48) | TSHRSRCTP53 | |
| SCHEMBL11054851 | 0.98 | TSHR (0.48) | TSHRSRCTP53 | |
| SCHEMBL17338717 | 0.98 | TSHR (0.48) | TSHRSRCTP53 | |
| Hydrochloric Acid SCHEMBL4441219 | 0.98 | TSHR (0.48) | TSHRSRCTP53 | |
| SCHEMBL1431069 | 0.97 | TSHR (0.45) | TSHRSRCTP53PGDMMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4132506-B1 | CARBOXYLATE LIGAND MODIFIED FERRIC IRON HYDROXIDE COMPOSITIONS FOR USE IN THE TREATMENT OR PREVENTION OF IRON DEFICIENCY ASSOCIATED WITH LIVER DISEASES | NEMYSIS LTD (IE) | 2024-05-15 | — | — | EP | claimed |
| US-11684572-B2 | Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses | UNITED KINGDOM RESEARCH AND INNOVATION (GB) | 2023-06-27 | — | — | US | claimed |
| US-20230134391-A1 | Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases | NEMYSIS Ltd. (IE) | 2023-05-04 | — | — | US | claimed |
| EP-4132506-A1 | CARBOXYLATE LIGAND MODIFIED FERRIC IRON HYDROXIDE COMPOSITIONS FOR USE IN THE TREATMENT OR PREVENTION OF IRON DEFICIENCY ASSOCIATED WITH LIVER DISEASES | Nemysis Limited (IE) | 2023-02-15 | — | — | EP | claimed |
| CN-108430964-B | Methods for producing carboxylate ligand-modified ferric hydroxide colloids, and related compositions and uses | 英国研究与创新署 | 2021-05-11 | — | — | CN | claimed |
| EP-3359519-B1 | METHODS FOR PRODUCING CARBOXYLATE LIGAND MODIFIED FERRIC IRON HYDROXIDE COLLOIDS AND RELATED COMPOSITIONS AND USES | RES & INNOVATION UK (GB) | 2020-08-12 | — | — | EP | claimed |
| US-20200155453-A1 | Methods for Producing Carboxylate Ligand Modified Ferric Iron Hydroxide Colloids and Related Compositions and Uses | MEDICAL RESEARCH COUNCIL (GB) | 2020-05-21 | — | — | US | claimed |
| US-10159661-B2 | Penicillin retard composition for intramuscular injection | SANDOZ AG (CH) | 2018-12-25 | — | — | US | claimed |
| US-20180271784-A1 | Methods for Producing Carboxylate Ligand Modified Ferric Iron Hydroxide Colloids and Related Compositions and Uses | MEDICAL RESEARCH COUNCIL (GB) | 2018-09-27 | — | — | US | claimed |
| US-20180036291-A1 | Penicillin Retard Composition For Intramuscular Injection | SANDOZ AG (CH) | 2018-02-08 | — | — | US | claimed |
| EP-2376678-B1 | SOLUTION AND PROCESS FOR INCREASING THE SOLDERABILITY AND CORROSION RESISTANCE OF A METAL OR METAL ALLOY SURFACE | ATOTECH DEUTSCHLAND GMBH (DE) | 2012-09-12 | — | — | EP | claimed |
| EP-2401227-A2 | REACTION TUBE AND HYDROTHERMAL PROCESSING FOR THE WET CHEMICAL CO-PRECIPITATION OF OXIDE POWDERS | Eestor, Inc. (US) | 2012-01-04 | — | — | EP | claimed |
| US-7976791-B2 | Portable chemical sterilizer | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 2011-07-12 | — | — | US | claimed |
| US-20110076152-A1 | VENTILATOR WHEEL OR FAN WHEEL WITH ANTIBACTERIAL COATING | EBM-PAPST MULFINGEN GMBH & CO. KG (DE) | 2011-03-31 | — | — | US | claimed |
| US-20110053758-A1 | REACTION TUBE AND HYDROTHERMAL PROCESSING FOR THE WET CHEMICAL CO-PRECIPITATION OF OXIDE POWDERS | EESTOR, INC. (US) | 2011-03-03 | — | — | US | claimed |
| EP-1228089-A2 | SALT FORM OF A CONJUGATE USEFUL IN THE TREATMENT OF PROSTATE CANCER | Merck & Co., Inc. (US) | 2002-08-07 | — | — | EP | claimed |
| US-6355611-B1 | SODIUM SALT OF PROSTATE SPECIFIC ANTIGEN CONJUGATE COMPOUND; USEFUL IN TREATMENT OF PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA | MERCK & CO., INC. | 2002-03-12 | — | — | US | claimed |
| WO-2001030804-A2 | SALT FORM OF A CONJUGATE USEFUL IN THE TREATMENT OF PROSTATE CANCER | MERCK & CO., INC. (US) | 2001-05-03 | — | — | WO | claimed |
| EP-0435012-B1 | 2-part hair dyeing agent | SUNSTAR KK (JP) | 1994-04-27 | — | — | EP | claimed |
| CN-1052043-A | 2-PART HAIR DYEING AGENTS | SUNSTAR KK (JP) | 1991-06-12 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10159661-B2 | Penicillin retard composition for intramuscular injection | GMPS, MMP1, ITPA | TSHR 3871/4885SRC 3302/4885TP53 3821/4885 |
| US-20180036291-A1 | Penicillin Retard Composition For Intramuscular Injection | GMPS, MMP1, ITPA | TSHR 3871/4885SRC 3302/4885TP53 3821/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.